Week In Review: Jiangsu's CTFH Signs $200 Million AI Drug Discovery Pact With Insilico
October 12, 2019 at 19:12 PM EDT
Jiangsu's CTFH Pharma formed a partnership worth up to $200 million with Insilico Medicine, which will use its AI technology to discover two triple-negative breast cancer candidates.
